HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HAIXI PHARMA

167.000

+0.9000.54%

Volume:236.65K

Turnover:38.95M

Market Cap:13.14B

PE:82.48

High:169.300

Open:167.600

Low:161.700

Close:166.100

52wk High:169.300

52wk Low:97.500

Shares:78.71M

HK Float Shares:78.71M

Volume Ratio:1.03

T/O Rate:0.30%

Dividend:- -

Dividend Rate:- -

EPS(LYR):2.025

ROE:28.75%

ROA:12.62%

PB:21.34

PE(LYR):82.48

PS:24.75

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

HAIXI PHARMA (02637) Sets 30 Mar 2026 Board Meeting to Approve FY 2025 Results and Consider Final Dividend

Bulletin Express

HAIXI PHARMA (02637) Announces Appointment of Liu Guoxian as Joint Company Secretary, Authorized Representative, and Legal Process Agent

Fujian Haixi Pharmaceuticals appoints Lau Kwok Yin as joint company secretary

HAIXI PHARMA (02637) Announces February 2026 Monthly Return on Share Movements

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/02637"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02637","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02637\",,,,,undefined,":{"symbol":"02637","market":"HK","secType":"STK","nameCN":"HAIXI PHARMA","latestPrice":167,"timestamp":1773216494082,"preClose":166.1,"halted":0,"volume":236650,"delay":0,"changeRate":0.005418422636965718,"floatShares":78707270,"shares":78707270,"eps":2.024774,"marketStatus":"Not Yet Opened","change":0.9,"latestTime":"03-11 16:08:14","open":167.6,"high":169.3,"low":161.7,"amount":38946185,"amplitude":0.045756,"askPrice":167,"askSize":250,"bidPrice":166.8,"bidSize":850,"shortable":0,"etf":0,"ttmEps":2.264,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1773279000000},"marketStatusCode":0,"adr":0,"listingDate":1760889600000,"exchange":"SEHK","adjPreClose":166.1,"openAndCloseTimeList":[[1773192600000,1773201600000],[1773205200000,1773216000000]],"volumeRatio":1.0289130434335256,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02637\",,,,,undefined,":{"symbol":"02637","floatShares":78707270,"roa":"12.62%","roe":"28.75%","lyrEps":2.024774,"volumeRatio":1.0289130434335256,"shares":78707270,"dividePrice":0,"high":169.3,"amplitude":0.045756,"preClose":166.1,"low":161.7,"week52Low":97.5,"pbRate":"21.34","psRate":"24.75","week52High":169.3,"institutionHeld":0,"latestPrice":167,"committee":0.545455,"eps":2.024774,"divideRate":0,"volume":236650,"delay":0,"ttmEps":2.264,"open":167.6,"prevYearClose":136,"prevWeekClose":125.3,"prevMonthClose":143,"prevQuarterClose":136,"fiveDayClose":137.7,"twentyDayClose":135.8,"sixtyDayClose":129.6,"earningDate":1774800000000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02637\",params:#limit:5,,,undefined,":[{"date":"2026-03-30","symbol":"02637","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02637\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02637\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02637\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02637","date":"2026-03-10","current":73.763251,"percent":1,"low":41.43616,"twenty":67.147849,"median":69.476642,"eighty":72.67988,"high":84.430189,"avg":69.343945,"sd":6.29329,"marketCap":13073277547},"quantilePoints":[{"date":"2025-10-16","current":41.43616,"twenty":41.43616,"median":41.43616,"eighty":41.43616,"marketCap":6150186077},{"date":"2025-10-24","current":58.044665,"twenty":53.788314,"median":54.742854,"eighty":58.044665,"marketCap":8618446065},{"date":"2025-10-31","current":63.409996,"twenty":54.11413,"median":58.177187,"eighty":60.582738,"marketCap":9429130946},{"date":"2025-11-07","current":65.038519,"twenty":55.071217,"median":59.875924,"eighty":63.533346,"marketCap":9665252756},{"date":"2025-11-14","current":69.713569,"twenty":57.493757,"median":61.562796,"eighty":68.778725,"marketCap":10389359640},{"date":"2025-11-21","current":66.575785,"twenty":58.2567,"median":64.026746,"eighty":69.208194,"marketCap":9917116020},{"date":"2025-11-28","current":68.072175,"twenty":59.478322,"median":65.807152,"eighty":68.767812,"marketCap":10176850011},{"date":"2025-12-05","current":68.42835,"twenty":59.854834,"median":66.893861,"eighty":68.767812,"marketCap":10247686554},{"date":"2025-12-12","current":69.403659,"twenty":60.326406,"median":67.279459,"eighty":69.361692,"marketCap":10412971821},{"date":"2025-12-19","current":69.502155,"twenty":61.237436,"median":67.861589,"eighty":69.423358,"marketCap":10452325456},{"date":"2025-12-24","current":72.521094,"twenty":61.537644,"median":68.055113,"eighty":69.462757,"marketCap":10940310530},{"date":"2026-01-02","current":68.547,"twenty":62.032842,"median":68.254334,"eighty":69.697511,"marketCap":10381488913},{"date":"2026-01-09","current":76.256401,"twenty":63.533346,"median":68.54394,"eighty":70.33117,"marketCap":11577839417},{"date":"2026-01-16","current":83.450154,"twenty":64.030428,"median":68.594109,"eighty":71.180851,"marketCap":12711224105},{"date":"2026-01-23","current":75.203122,"twenty":64.243828,"median":68.851274,"eighty":73.407226,"marketCap":11444037058},{"date":"2026-01-30","current":72.029156,"twenty":65.345972,"median":69.26967,"eighty":73.580372,"marketCap":11011147073},{"date":"2026-02-06","current":69.741329,"twenty":66.631937,"median":69.18814,"eighty":73.524909,"marketCap":10688447266},{"date":"2026-02-13","current":69.700471,"twenty":66.864009,"median":69.376262,"eighty":73.289662,"marketCap":10743542355},{"date":"2026-02-20","current":69.085102,"twenty":66.878935,"median":69.376262,"eighty":72.984771,"marketCap":10633352177},{"date":"2026-02-27","current":72.331605,"twenty":67.046254,"median":69.403659,"eighty":72.584608,"marketCap":11255139610},{"date":"2026-03-06","current":63.89376,"twenty":67.046254,"median":69.448144,"eighty":72.584608,"marketCap":9862020931},{"date":"2026-03-10","current":84.430189,"twenty":67.147849,"median":69.476642,"eighty":72.67988,"marketCap":13073277547}],"updateTime":1773259387565},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02637\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1148839371","title":"HAIXI PHARMA (02637) Sets 30 Mar 2026 Board Meeting to Approve FY 2025 Results and Consider Final Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1148839371","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148839371?lang=en_us&edition=fundamental","pubTime":"2026-03-10 16:44","pubTimestamp":1773132298,"startTime":"0","endTime":"0","summary":"Fujian Haixi Pharmaceuticals Co., Ltd. (HAIXI PHARMA, 02637) has scheduled a board meeting for Monday, 30 March 2026. The agenda includes: • Reviewing and approving the Group’s consolidated results...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637"],"gpt_icon":0},{"id":"1175166735","title":"HAIXI PHARMA (02637) Announces Appointment of Liu Guoxian as Joint Company Secretary, Authorized Representative, and Legal Process Agent","url":"https://stock-news.laohu8.com/highlight/detail?id=1175166735","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175166735?lang=en_us&edition=fundamental","pubTime":"2026-03-06 16:43","pubTimestamp":1772786581,"startTime":"0","endTime":"0","summary":"HAIXI PHARMA (02637) announced that Ms. Lin Huiyi has resigned from her positions as the company's Joint Company Secretary; the authorized representative of the company as stipulated under Rule 3.05...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02637"],"gpt_icon":0},{"id":"2617683673","title":"Fujian Haixi Pharmaceuticals appoints Lau Kwok Yin as joint company secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=2617683673","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617683673?lang=en_us&edition=fundamental","pubTime":"2026-03-06 16:36","pubTimestamp":1772786187,"startTime":"0","endTime":"0","summary":"Fujian Haixi Pharmaceuticals Co. Ltd. said Sophie Lam Wai Yee has resigned as joint company secretary, authorised representative and process agent, effective 6 March 2026. The company appointed Lau Kwok Yin as joint company secretary, authorised representative and process agent from 6 March 2026. Lau is a vice president in the Listed Corporate Secretarial Department at SWCS Corporate Services Group  and has over 15 years of experience in corporate secretarial services, finance and banking operations. Zhang Junhuan will remain as joint company secretary.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fujian Haixi Pharmaceuticals Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Serv","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nNDL5CfzpH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02637"],"gpt_icon":0},{"id":"1168367303","title":"HAIXI PHARMA (02637) Announces February 2026 Monthly Return on Share Movements","url":"https://stock-news.laohu8.com/highlight/detail?id=1168367303","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168367303?lang=en_us&edition=fundamental","pubTime":"2026-03-05 17:26","pubTimestamp":1772702807,"startTime":"0","endTime":"0","summary":"Fujian Haixi Pharmaceuticals Co., Ltd. (stock code: 02637) published its monthly return on movements in securities for the period ended 28 February 2026. The announcement indicates that the total...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637"],"gpt_icon":0}],"pageSize":4,"totalPage":8,"pageCount":1,"totalSize":32,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/02637\",params:#limit:6,delay:false,,,undefined,":[]}}